STUDIES ON THE INHIBITION OF PROTEOLYTIC ENZYMES BY SERUM
N. Raphael Shulman
Abstract
Open-access reader
N. Raphael Shulman
Abstract
Open-access reader
Increases in serum proteolytic inhibition with disease were found to be specific either for plasmin or for trypsin and chymotrypsin. In normal serum, the plasmin inhibitor could be differentiated from the trypsin and chymotrypsin inhibitor by various physical and chemical means. There was no apparent difference between the trypsin inhibitor and the chymotrypsin inhibitor in serum. No qualitative differences were found between the inhibitors of normal sera and the inhibitors of sera showing elevated inhibition.
OpenAlex reports 70 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Increases in serum proteolytic inhibition with disease were found to be specific either for plasmin or for trypsin and chymotrypsin. In normal serum, the plasmin inhibitor could be differentiated from the trypsin and chymotrypsin inhibitor by various physical and chemical means. There was no apparent difference between the trypsin inhibitor and the chymotrypsin inhibitor in serum. No qualitative differences were found between the inhibitors of normal sera and the inhibitors of sera showing elevated inhibition.
Key concepts: Plasmin, Trypsin, Chymotrypsin, Proteolytic enzymes, Enzyme, Biochemistry, Chemistry, Trypsin inhibitor